#pfizer

[ follow ]
Public health
fromMail Online
2 weeks ago

Scientists discover Pfizer COVID jab linked to eye damage risk

Pfizer's COVID-19 vaccine may increase the risk of eye damage and vision loss, particularly affecting the cornea.
#investing
Business
fromBusiness Insider
2 weeks ago

She helped launch Pfizer's COVID-19 vaccine in the depths of the pandemic. Now, she's planning her next act.

Sally Susman will leave her position at Pfizer at the end of 2025 after nearly two decades of service.
fromAdExchanger
3 weeks ago

Why Pfizer's Josh Palau Can't Wait To Buy Netflix Through The Yahoo DSP | AdExchanger

Part of moving biddable marketing channels in-house is having a deeper understanding of the brand. At an agency, the focus can often be diluted across various clients.
E-Commerce
fromIrish Independent
3 weeks ago

EU president Ursula von der Leyen easily survives 'destabilising' confidence vote

Ursula von der Leyen survives a no confidence vote, indicating her strong legislative support.
from24/7 Wall St.
4 weeks ago

U.S. Awards Lockheed Martin a Record $68.5B, Larger Than the Next Two Contractors Combined

HII Mission Technologies earns approximately $4.5 billion annually, accounting for 1% of all DoD contract spending by developing unmanned underwater vehicles and drones for naval missions.
US politics
#stock-market
#dividend-stocks
fromFuturism
2 months ago

400 Women Are Suing Pfizer Over Birth Control Shot That Allegedly Gave Them Brain Tumors

Pfizer's Depo-Provera birth control shot is linked to an increased risk of brain tumors, prompting a class action lawsuit from hundreds of women.
fromNew York Post
2 months ago

Pfizer scientist claimed delay of COVID jab results until after 2020 election 'wasn't a coincidence,' House GOP panel alleges

Allegations suggest Pfizer executives might have intentionally delayed vaccine results to influence the 2020 presidential election.
Europe news
fromwww.theguardian.com
2 months ago

Von der Leyen's texts with Pfizer boss can be shared, says EU's highest court

EU court ruling forces Ursula von der Leyen to reconsider transparency about text messages with a pharmaceutical executive during the pandemic.
NYC startup
from24/7 Wall St.
2 months ago

Pfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?

Pfizer's stock is at a 13-year low, driven by declining COVID-19 sales and tariff uncertainties.
Sustaining dividend payouts is a challenge due to insufficient free cash flow.
from24/7 Wall St.
3 months ago

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (May 2025)

Pfizer's stocks have struggled in 2025, down 23% from their yearly high, despite exceeding EPS expectations but falling short in revenue due to COVID product sales decline.
NYC startup
European startups
fromBusiness Insider
3 months ago

Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away

Tariff uncertainty is limiting Pfizer's investment potential in R&D and manufacturing in the US.
fromtime.com
3 months ago

Pfizer Ends Development of Its Obesity Pill

Pfizer's decision to halt danuglipron development underscores the risks and complexities involved in creating new obesity treatments, particularly after significant financial investment and testing phases.
Wearables
US Elections
fromBusiness Insider
4 months ago

Pfizer's CEO says he's got a plan to deal with Trump's tariffs - move overseas drug manufacturing to the US

Pfizer may relocate drug manufacturing back to the US in response to Trump's tariffs.
from24/7 Wall St.
8 months ago

Opinion: Pfizer (PFE) Stock Will Hit $22 Before It Hits $33 During Trump's Presidency

Donald Trump's electoral victory has unexpectedly led to market gains, with the S&P 500 rising 5% shortly after the election. However, not all sectors have prospered, particularly pharmaceuticals.
Miscellaneous
#art-conservation
[ Load more ]